Hasil Pencarian - Sushil Immanuel

  • Menampilkan 1 - 3 hasil dari 3
Perbaiki Hasil
  1. 1
    SARS-CoV-2 infections before, during, and after the Omicron wave: a 2-year Indian community cohort studyResearch in context

    SARS-CoV-2 infections before, during, and after the Omicron wave: a 2-year Indian community cohort studyResearch in context oleh Ramya Madhavan, Jackwin Sam Paul, Sudhir Babji, Isai Thamizh, Dilesh Kumar, Shainey Alokit Khakha, Aarene Rennie, Keerthana Kumar, Pavithra Dhanapal, Poornima Saravanan, Ajith Kumar, Sushil Immanuel, Vaishnavi Gandhi, Anand Kumar, Johnson John Babu, Nandu Thrithamarassery Gangadharan, Premkumar Jagadeesan, Elizabeth John, Colin Jamora, Dasaradhi Palakodeti, Rubina Bhati, Saranya Devi Thambidurai, Arati Suvatha, Anna George, Gagandeep Kang, Jacob John

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants

    Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants oleh Edward P. K. Parker, Christina Bronowski, Kulandaipalayam Natarajan C. Sindhu, Sudhir Babji, Blossom Benny, Noelia Carmona-Vicente, Nedson Chasweka, End Chinyama, Nigel A. Cunliffe, Queen Dube, Sidhartha Giri, Nicholas C. Grassly, Annai Gunasekaran, Deborah Howarth, Sushil Immanuel, Khuzwayo C. Jere, Beate Kampmann, Jenna Lowe, Jonathan Mandolo, Ira Praharaj, Bakthavatsalam Sandya Rani, Sophia Silas, Vivek Kumar Srinivasan, Mark Turner, Srinivasan Venugopal, Valsan Philip Verghese, Alistair C. Darby, Gagandeep Kang, Miren Iturriza-Gómara

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational studyResearch in context

    Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observ... oleh Mangaiarkarasi S. Asokan, Roshni Florina Joan, Sudhir Babji, Girish Dayma, Prajitha Nadukkandy, Vinutha Subrahmanyam, Archana Pandey, Girish Malagi, Pooja Arya, Vibhuti Mahajan, Jayateerth Bhavikatti, Ketakee Pawar, Aishwarya Thorat, Priyanki Shah, Ramakrishna B. Goud, Bishnudeo Roy, Shon Rajukutty, Sushil Immanuel, Dhiraj Agarwal, Sankhanil Saha, Akshatha Shivaraj, Patricia Panikulam, Rajeshwari Shome, Shah-E-Jahan Gulzar, Anusmrithi U. Sharma, Ajinkya Naik, Shruti Talashi, Madhuri Belekar, Ritu Yadav, Poornima Khude, Mamatha V, Sudarshan Shivalingaiah, Urmila Deshmukh, Chinmayee Bhise, Manjiri Joshi, Leeberk Raja Inbaraj, Sindhulina Chandrasingh, Aurnab Ghose, Colin Jamora, Anandi S. Karumbati, Varadharajan Sundaramurthy, Avita Johnson, Naveen Ramesh, Nirutha Chetan, Chaitra Parthiban, Asma Ahmed, Srabanti Rakshit, Vasista Adiga, George D'souza, Vinay Rale, Carolin Elizabeth George, Jacob John, Anand Kawade, Akanksha Chaturvedi, Anu Raghunathan, Mary Dias, Anand Bhosale, Padinjat Raghu, L.S. Shashidhara, Annapurna Vyakarnam, Vineeta Bal, Gagandeep Kang, Satyajit Mayor

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: